A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece-Reference-Cited by-同舟云学术

A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece

Published:2023-09-08 Issue:9 Volume:15 Page:561
ISSN:2072-6651
Container-title:Toxins
language:en
Short-container-title:Toxins

Author:

Nomikos Nikolaos¹^ORCID,Eleftheriou Christos²,Athanasakis Kostas¹

Affiliation:

1. Laboratory for Health Technology Assessment, Department of Public Health Policy, School of Public Health, University of West Attica, 11521 Athens, Greece

2. Ipsen Mepe, 17456 Athens, Greece

Abstract

This study aimed to assess the cost-effectiveness of abobotulinumtoxinA (aboBoNT-A) plus Best Supportive Care (BSC) compared with BSC alone for managing limb spasticity in adult patients in Greece, as well as to conduct a budget impact analysis of the introduction of aboBoNT-A in the Greek healthcare system compared to onabotulinumtoxinA (onaBoNT-A). Clinical studies were utilized to extract data on drug efficacy and patients’ utility, while cost data were collected from Greek sources. The results of the study showed that aboBoNT-A plus BSC was a cost-effective treatment option for both upper and lower limb spasticity in adult patients compared to BSC. Additionally, introducing aboBoNT-A into the Greek healthcare system resulted in cost savings in pharmaceutical spending over a 5-year period. The findings suggest that incorporating aboBoNT-A into the Greek healthcare system could improve patient access to treatment and healthcare resource efficiency, as it is a more economical option compared to onaBoNT-A.

Funder

Ipsen

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

https://www.mdpi.com/2072-6651/15/9/561/pdf

Reference30 articles.

1. Spasticity—Pathogenesis, Prevention and Treatment Strategies;Ghai;Saudi J. Anaesth.,2013

2. Defining Spasticity: A New Approach Considering Current Movement Disorders Terminology and Botulinum Toxin Therapy;Dressler;J. Neurol.,2018

3. Nalysnyk, L., Papapetropoulos, S., Rotella, P., Simeone, J.C., Alter, K.E., and Esquenazi, A. (2013). OnabotulinumtoxinA Muscle Injection Patterns in Adult Spasticity: A Systematic Literature Review. BMC Neurol., 13.

4. Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity;Dashtipour;Medicine,2016

5. Royal College of Physicians of London, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy (Great Britain), and Association of Chartered Physiotherapists in Neurology (2008). Royal College of Occupational Therapists Spasticity in Adults: Management Using Botulinum Toxin: National Guidelines, Royal College of Physicians.